Latest Avidity Partners Management LP Stock Portfolio
Avidity Partners Management LP Performance:
2024 Q4: -6.23%YTD: 5.21%2023: 6.74%
Performance for 2024 Q4 is -6.23%, and YTD is 5.21%, and 2023 is 6.74%.
About Avidity Partners Management LP and 13F Hedge Fund Stock Holdings
Avidity Partners Management LP is a hedge fund based in DALLAS, TX. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $9.2 Billions. In it's latest 13F Holdings report, Avidity Partners Management LP reported an equity portfolio of $1 Billions as of 31 Dec, 2024.
The top stock holdings of Avidity Partners Management LP are , BSX, JANX. The fund has invested 6.2% of it's portfolio in DIANTHUS THERAPEUTICS INC and 4.5% of portfolio in BOSTON SCIENTIFIC CORP.
The fund managers got completely rid off BIOMARIN PHARMACEUTICAL INC (BMRN), ARGENX SE and TERNS PHARMACEUTICALS INC (TERN) stocks. They significantly reduced their stock positions in COGENT BIOSCIENCES INC (COGT), UNIQURE NV (QURE) and ILLUMINA INC (ILMN). Avidity Partners Management LP opened new stock positions in REGENERON PHARMACEUTICALS (REGN), BRUKER CORP (BRKR) and VERA THERAPEUTICS INC (VERA). The fund showed a lot of confidence in some stocks as they added substantially to TRANSMEDICS GROUP INC (TMDX), ROCKET PHARMACEUTICALS INC (RCKT) and DEXCOM INC (DXCM).
The top stock holdings of Avidity Partners Management LP are , BSX, JANX. The fund has invested 6.2% of it's portfolio in DIANTHUS THERAPEUTICS INC and 4.5% of portfolio in BOSTON SCIENTIFIC CORP.
The fund managers got completely rid off BIOMARIN PHARMACEUTICAL INC (BMRN), ARGENX SE and TERNS PHARMACEUTICALS INC (TERN) stocks. They significantly reduced their stock positions in COGENT BIOSCIENCES INC (COGT), UNIQURE NV (QURE) and ILLUMINA INC (ILMN). Avidity Partners Management LP opened new stock positions in REGENERON PHARMACEUTICALS (REGN), BRUKER CORP (BRKR) and VERA THERAPEUTICS INC (VERA). The fund showed a lot of confidence in some stocks as they added substantially to TRANSMEDICS GROUP INC (TMDX), ROCKET PHARMACEUTICALS INC (RCKT) and DEXCOM INC (DXCM).
Avidity Partners Management LP Annual Return Estimates Vs S&P 500
Our best estimate is that Avidity Partners Management LP made a return of -6.23% in the last quarter. In trailing 12 months, it's portfolio return was 5.21%.
New Buys
| Ticker | $ Bought |
|---|---|
| regeneron pharmaceuticals | 5,983,570 |
| bruker corp | 4,472,710 |
| vera therapeutics inc | 4,229,000 |
| kezar life sciences inc | 3,377,470 |
| akero therapeutics inc | 2,281,240 |
| bluebird bio inc | 680,169 |
New stocks bought by Avidity Partners Management LP
Additions
| Ticker | % Inc. |
|---|---|
| transmedics group inc | 597 |
| rocket pharmaceuticals inc | 40.63 |
| dexcom inc | 32.5 |
| janux therapeutics inc | 32.01 |
| exact sciences corp | 2.55 |
| context therapeutics inc | 0.81 |
Additions to existing portfolio by Avidity Partners Management LP
Reductions
| Ticker | % Reduced |
|---|---|
| cogent biosciences inc | -71.32 |
| uniqure nv | -67.04 |
| illumina inc | -62.43 |
| insmed inc | -60.68 |
| newamsterdam pharma company | -60.21 |
| natera inc | -59.78 |
| intra-cellular therapies inc | -58.37 |
| incyte corp | -57.94 |
Avidity Partners Management LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| terns pharmaceuticals inc | -17,796,500 |
| bluebird bio inc | -847,379 |
| editas medicine inc | -4,995,650 |
| syros pharmaceuticals inc | -2,285,450 |
| cybin inc | -8,161,020 |
| prelude therapeutics inc | -1,842,300 |
| immunome inc | -12,776,300 |
| prime medicine inc | -2,685,780 |
Avidity Partners Management LP got rid off the above stocks
Sector Distribution
Avidity Partners Management LP has about 85.3% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 85.3 |
| Others | 12.7 |
| Basic Materials | 2 |
Market Cap. Distribution
Avidity Partners Management LP has about 40.4% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 33.6 |
| MID-CAP | 29.4 |
| SMALL-CAP | 14.3 |
| UNALLOCATED | 13.6 |
| MEGA-CAP | 6.8 |
| MICRO-CAP | 2 |
Stocks belong to which Index?
About 59.3% of the stocks held by Avidity Partners Management LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 40.6 |
| RUSSELL 2000 | 34.2 |
| S&P 500 | 25.1 |
Avidity Partners Management LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Avidity Partners Management LP
Avidity Partners Management LP has 61 stocks in it's portfolio. About 36.6% of the portfolio is in top 10 stocks. ACHC proved to be the most loss making stock for the portfolio. NTRA was the most profitable stock for Avidity Partners Management LP last quarter.
Last Reported on: 14 Feb, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABBV | abbvie inc | 1.41 | 80,700 | 14,340,400 | reduced | -19.3 | ||
| ACHC | acadia healthcare company in | 2.56 | 658,000 | 26,089,700 | reduced | -33.2 | ||
| AKRO | akero therapeutics inc | 0.22 | 82,000 | 2,281,240 | new | |||
| ARVN | arvinas inc | 2.56 | 1,358,000 | 26,032,900 | reduced | -9.29 | ||
| AVTR | avantor inc | 1.96 | 947,000 | 19,953,300 | reduced | -23.32 | ||
| AXSM | axsome therapeutics inc | 1.56 | 188,000 | 15,906,700 | reduced | -36.51 | ||
| BMRN | biomarin pharmaceutical inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMY | bristol-myers squibb co | 1.19 | 215,000 | 12,160,400 | reduced | -18.25 | ||
| BPMC | blueprint medicines corp | 1.51 | 176,600 | 15,403,100 | reduced | -43.94 | ||
| BRKR | bruker corp | 0.44 | 76,300 | 4,472,710 | new | |||
| BSX | boston scientific corp | 4.52 | 515,000 | 45,999,800 | reduced | -46.47 | ||
| CGEM | cullinan therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CMAX | caremax inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CNTA | centessa pharmaceuticals plc | 1.92 | 1,165,800 | 19,527,200 | reduced | -45.32 | ||
| CNTX | context therapeutics inc | 0.77 | 7,477,200 | 7,851,060 | added | 0.81 | ||
| COGT | cogent biosciences inc | 0.22 | 287,104 | 2,239,410 | reduced | -71.32 | ||
| CYBN | cybin inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DHR | danaher corporation | 1.51 | 67,000 | 15,379,800 | reduced | -29.47 | ||
| DXCM | dexcom inc | 2.43 | 318,000 | 24,730,900 | added | 32.5 | ||
| DYN | dyne therapeutics inc | 0.22 | 96,000 | 2,261,760 | reduced | -41.82 | ||